Additional file 2: Table S1. of Characteristics and outcomes of patients with type 2 diabetes mellitus treated with canagliflozin: a real-world analysis

Baseline characteristics of patients with T2DM with baseline and follow-up A1C measurements treated with canagliflozin. A1C, glycated hemoglobin; DCSI, diabetes complication severity index; OB/GYM, obstetric/gynecology; SD, standard deviation. (DOC 36 kb)